Yoshino T, Asada H, Sano S, Nakamura T, Itami S, Tamura M, Yoshikawa K
Departments of Dermatology and *Otorhinolaryngology, Osaka University Medical School, Osaka, Japan.
J Invest Dermatol. 2000 Feb;114(2):281-8. doi: 10.1046/j.1523-1747.2000.00878.x.
Staphylococcus aureus colonization is an almost universal feature of atopic dermatitis. In order to investigate the role of staphylococcal enterotoxin B in the pathogenesis of atopic dermatitis, we assessed the correlation between clinical disease severity and proliferative response of peripheral blood mononuclear cells to staphylococcal enterotoxin B in patients with atopic dermatitis. Peripheral blood mononuclear cells from patients with mild atopic dermatitis showed significantly increased proliferative responses to staphylococcal enterotoxin B compared to controls. In contrast, peripheral blood mononuclear cells from patients with severe atopic dermatitis showed markedly suppressed proliferative responses. Additionally, longitudinal evaluation of peripheral blood mononuclear cell samples from the same patient demonstrated that proliferative responses were suppressed only at times of severe disease exacerbation. Mixing experiments, using autologous T cells and antigen presenting cells that were isolated at different time points from the same patient, demonstrated that T cells of severe atopic dermatitis patients were dysfunctional, but their antigen presenting cell function remained intact. We found no significant differences of interleukin-2 levels in the culture supernatants between healthy controls and atopic dermatitis groups. Fluorescence-activated cell sorter analysis for APO2.7 antigen, an early apoptosis cell marker, demonstrated that approximately 60% of staphylococcal-enterotoxin-B-stimulated T cells expressed APO2.7 antigen in severe atopic dermatitis cases. By contrast, 5%-20% of T cells expressed APO2.7 after staphylococcal enterotoxin B stimulation in cases of mild atopic dermatitis and in healthy controls. Nuclear staining with Hoechst 33258 also showed approximately 40% apoptotic cells in the CD19-CD16-PBMC of severe atopic dermatitis patients, compared with only 5%-10% in the mild atopic dermatitis group and in healthy controls. Blocking monoclonal antibody to Fas ligand partially prevented the staphylococcal-enterotoxin-B-induced apoptosis detected by APO2.7 expression and Hoechst 33258 staining. Suppressed proliferation of peripheral blood mononuclear cells in severe atopic dermatitis patients may be secondary to T cell death by apoptosis. These results suggest that an infection of S. aureus producing staphylococcal enterotoxin B may play a role in aggravation of atopic dermatitis by inducing apoptosis in T cells.
金黄色葡萄球菌定植是特应性皮炎几乎普遍存在的特征。为了研究葡萄球菌肠毒素B在特应性皮炎发病机制中的作用,我们评估了特应性皮炎患者临床疾病严重程度与外周血单核细胞对葡萄球菌肠毒素B增殖反应之间的相关性。与对照组相比,轻度特应性皮炎患者的外周血单核细胞对葡萄球菌肠毒素B的增殖反应显著增加。相反,重度特应性皮炎患者的外周血单核细胞增殖反应明显受到抑制。此外,对同一患者外周血单核细胞样本的纵向评估表明,增殖反应仅在疾病严重加重时受到抑制。混合实验使用从同一患者不同时间点分离的自体T细胞和抗原呈递细胞,结果表明重度特应性皮炎患者的T细胞功能失调,但其抗原呈递细胞功能保持完整。我们发现健康对照组和特应性皮炎组之间培养上清液中的白细胞介素-2水平没有显著差异。对早期凋亡细胞标志物APO2.7抗原进行荧光激活细胞分选分析表明,在重度特应性皮炎病例中,约60%的葡萄球菌肠毒素B刺激的T细胞表达APO2.7抗原。相比之下,在轻度特应性皮炎病例和健康对照组中,5%-20%的T细胞在葡萄球菌肠毒素B刺激后表达APO2.7。用Hoechst 33258进行核染色还显示,重度特应性皮炎患者的CD19-CD16-PBMC中约40%为凋亡细胞,而轻度特应性皮炎组和健康对照组中仅为5%-10%。针对Fas配体的阻断单克隆抗体部分阻止了通过APO2.7表达和Hoechst 33258染色检测到的葡萄球菌肠毒素B诱导的凋亡。重度特应性皮炎患者外周血单核细胞增殖受抑制可能继发于T细胞凋亡死亡。这些结果表明,产生葡萄球菌肠毒素B的金黄色葡萄球菌感染可能通过诱导T细胞凋亡在特应性皮炎加重中起作用。